Portage Biotech Announces Results for Fiscal Quarter Ended
--Updated Data on Phase 1/2 Trial Evaluating PORT-2 Presented at the Society for Immunotherapy of Cancer’s (SITC) Annual Meeting-- --Clinical...
United States Development Agreement Society For Immunotherapy Of Cancer American Society Of Clinical Oncology Development Committee Merck Co
Source: globenewswire.com